We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Multi Sample Osmometer Improves Testing Efficiency

By LabMedica International staff writers
Posted on 03 Aug 2016
Image: The OsmoPRO multi-sample osmometer for automated testing (Photo courtesy of Advanced Instruments).
Image: The OsmoPRO multi-sample osmometer for automated testing (Photo courtesy of Advanced Instruments).
A novel 20-position micro sample osmometer improves laboratory efficiency, productivity, and workflow by reducing sample turn-around time.

The OsmoPRO Multi-Sample Osmometer for automated osmolality testing is designed to analyze a variety of complex aqueous mixtures, including blood, serum, plasma, urine, cell culture media, drug formulations, and biological cell therapies, using a small, 20 μL sample size. Samples can be analyzed one at a time, or batch processed depending on workflow demands. Timesaving features include an intuitive touch screen, automated processing, and the ability to run unattended. The device also uses the freezing point depression method to deliver results in just two minutes.

The OsmoPRO can be used in a variety of laboratory applications including clinical diagnostics, formulation development, bioprocess monitoring and process control, industrial, environmental, and finished product quality control. An integrated barcode scanner provides positive sample identification to reduce transcription errors, with data management and transfer handled via the on-board printer or by exporting the data using an ethernet connection and multiple USB ports. The OsmoPRO multi-sample osmometer, a product of Advanced Instruments (Norwood, MA, USA), will be presented at AACC 2016.

“OsmoPRO incorporates more than 60 years of applied technology and expertise from Advanced Instruments, the industry leader in the field of osmometry,” said Peter Costas, vice president of sales and marketing at Advanced Instruments. “OsmoPRO replaces the Advanced Model 2020 osmometer, which has been an extremely popular and reliable osmometer used in thousands of laboratories worldwide, and represents Advanced Instruments commitment to quality and innovation in the field of osmometry”.

Osmometers are used for measuring the osmotic strength of a solution, colloid, or compound, or determining the molecular weight of unknown compounds and polymers. Several techniques can be used, including vapor pressure depression to determine the concentration of osmotically active particles; determining the osmotic pressure of a solution separated from pure solvent by a semipermeable membrane; and freezing point depression to determine osmotically active compounds in a solution.

The American Association for Clinical Chemistry (AACC; Washington, DC, USA) is an international scientific/medical society of over 8,000 clinical laboratory professionals, physicians, research scientists and more. The AACC annual meeting, which will be held from July 31st to August 4th at the Pennsylvania Convention Center in Philadelphia (USA), features five days of educational sessions on scientific, clinical, technical and management challenges facing laboratory professionals, as well as the world’s largest Clinical Lab Expo.

Related Links:
Advanced Instruments
American Association for Clinical Chemistry
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Online QC Software
Acusera 24•7
Automated Clinical Chemistry Analyzer
Envoy 500+
New
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.

Channels

Clinical Chemistry

view channel
Image: Illustration of the new blood test, which uses a DNA chip to detect the tumor’s biological fingerprint (Photo courtesy of Tel Aviv University)

Blood Test on a Chip Offers Low-Cost Lung Cancer Detection Without DNA Sequencing

Lung cancer is the leading cause of cancer deaths worldwide, and screening often yields indeterminate results that prompt invasive workups. Computed tomography (CT) detects small nodules but can flag benign... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Whole-Cell Genomic Analysis Expands the Potential of Liquid Biopsy

Liquid biopsy has expanded access to tumor genomics, but most blood-based assays rely on short, degraded fragments of cell-free circulating tumor DNA (ctDNA). Isolating intact circulating tumor cells from... Read more

Microbiology

view channel
Image: An innovative countywide program in Taiwan combines risk-based screening with decentralized community care to improve hepatitis C detection and treatment (Image Credit: iStock)

Precision Screening Helps Close Hepatitis C Diagnosis and Treatment Gaps

Hepatitis C remains a leading cause of cirrhosis and liver cancer, yet many infections go undiagnosed or untreated because health systems fail to reach those at greatest risk. Although highly effective... Read more

Pathology

view channel
Image: Through the PCCP, Proscia gains a more efficient pathway to expand Concentriq AP-Dx interoperability while maintaining regulatory oversight (Photo courtesy of Proscia)

FDA-Cleared Digital Pathology Platform Expands Interoperability for Primary Diagnosis

Rising cancer incidence is colliding with a shrinking pathologist workforce, intensifying pressure on diagnostic turnaround times in clinical laboratories. Many labs are adopting digital pathology to manage... Read more